CD133-Targeted Natural Killer Cell Therapy for Aggressive Variant Prostate Cancer

Project: Research project

Description

CD133-Targeted Natural Killer Cell Therapy for Aggressive Variant Prostate Cancer
StatusActive
Effective start/end date12/31/1812/31/20

Funding

  • Prostate Cancer Foundation

Fingerprint

Cell- and Tissue-Based Therapy
Natural Killer Cells
Prostatic Neoplasms